📰 Diagnostics Accelerator News
Page 3 - Diagnostics Accelerator News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diagnostics Accelerator. Real-time updates on events, politics, business and more.
May 5, 2022
Key Prominent Players Covered in the Alzheimer’s Drugs Market Research Report Are Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Eli Lilly and Company.,...
March 29, 2022
Funding will power a series of prospective clinical trials to validate Quanterix' multi-analyte test in collaboration with Amsterdam University Medical Centers (Amsterdam UMC) Quanterix Corporation
March 1, 2022
Fujirebio enters the field of fully automated blood-based Alzheimer’s disease biomarker testing with the release of the Lumipulse® G pTau 181 Plasma assay for Research Use Only - read this article along with other careers information, tips and advice on BioSpace
December 21, 2021
New York, NY (PRWEB) December 21, 2021 -- The Alzheimer’s Drug Discovery Foundation (ADDF) and Target ALS announced today a new partnership to identify and
December 7, 2021
Cataracts affect most older adults at risk for dementia, and now researchers are finding strong evidence that cataract surgery is associated with a lower
December 6, 2021
Cataracts affect most older adults at risk for dementia, and now researchers are finding strong evidence that cataract surgery is associated with a lower risk of developing dementia.
December 6, 2021
Getty Images Cataract surgery was also associated with lower risk of Alzheimer disease dementia specifically. Cataracts affect most older adults at
November 3, 2021
/PRNewswire/ -- A more robust pipeline of novel targets spanning all clinical trial phases and an ongoing focus on therapeutics driven by the biology of aging...
November 3, 2021
/PRNewswire/ -- A more robust pipeline of novel targets spanning all clinical trial phases and an ongoing focus on therapeutics driven by the biology of aging...
November 3, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.